The data presented for EGFR mutated and TP53 co-mutated NSCLC patients might stipulate for a systematic and regular MRI imaging of the brain as part of the follow up of these patients at high risk for developing brain metastases. Here, EGFR is linked to non-small cell lung carcinoma.